Cargando…
Paradigm shift of drug information centers during the COVID-19 pandemic
The novel coronavirus disease 2019 (COVID-19) pandemic is a major global threat affecting millions of lives throughout the world physically and psychologically. With the asymptomatic presentation of COVID-19 in many patients and the similarity of its symptoms with the common cold and influenza, the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370873/ https://www.ncbi.nlm.nih.gov/pubmed/32837192 http://dx.doi.org/10.1007/s40267-020-00757-3 |
_version_ | 1783561049764528128 |
---|---|
author | Khatiwada, Asmita Priyadarshini Shakya, Sujyoti Shrestha, Sunil |
author_facet | Khatiwada, Asmita Priyadarshini Shakya, Sujyoti Shrestha, Sunil |
author_sort | Khatiwada, Asmita Priyadarshini |
collection | PubMed |
description | The novel coronavirus disease 2019 (COVID-19) pandemic is a major global threat affecting millions of lives throughout the world physically and psychologically. With the asymptomatic presentation of COVID-19 in many patients and the similarity of its symptoms with the common cold and influenza, the need for accurate information on the disease is very important for its identification and proper management. Accurate information on the disease, its prevention and treatment can be disseminated through drug information centers (DICs). DICs are usually staffed by pharmacists and/or clinical pharmacists/pharmacologists. DICs are a reliable source of current and unbiased information on COVID-19 and its associated complications, including management options for healthcare professionals and the public. In addition to health and drug information, pharmacists working in the DICs can be involved in the management of the patients’ health by providing information on home care and safety, medication management of patients with chronic comorbid illnesses, and psychological advice. This article explores the possible additional roles DICs can play, besides providing drug information within the hospital or in the community. |
format | Online Article Text |
id | pubmed-7370873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-73708732020-07-20 Paradigm shift of drug information centers during the COVID-19 pandemic Khatiwada, Asmita Priyadarshini Shakya, Sujyoti Shrestha, Sunil Drugs Ther Perspect Current Opinion The novel coronavirus disease 2019 (COVID-19) pandemic is a major global threat affecting millions of lives throughout the world physically and psychologically. With the asymptomatic presentation of COVID-19 in many patients and the similarity of its symptoms with the common cold and influenza, the need for accurate information on the disease is very important for its identification and proper management. Accurate information on the disease, its prevention and treatment can be disseminated through drug information centers (DICs). DICs are usually staffed by pharmacists and/or clinical pharmacists/pharmacologists. DICs are a reliable source of current and unbiased information on COVID-19 and its associated complications, including management options for healthcare professionals and the public. In addition to health and drug information, pharmacists working in the DICs can be involved in the management of the patients’ health by providing information on home care and safety, medication management of patients with chronic comorbid illnesses, and psychological advice. This article explores the possible additional roles DICs can play, besides providing drug information within the hospital or in the community. Springer International Publishing 2020-07-20 2020 /pmc/articles/PMC7370873/ /pubmed/32837192 http://dx.doi.org/10.1007/s40267-020-00757-3 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Current Opinion Khatiwada, Asmita Priyadarshini Shakya, Sujyoti Shrestha, Sunil Paradigm shift of drug information centers during the COVID-19 pandemic |
title | Paradigm shift of drug information centers during the COVID-19 pandemic |
title_full | Paradigm shift of drug information centers during the COVID-19 pandemic |
title_fullStr | Paradigm shift of drug information centers during the COVID-19 pandemic |
title_full_unstemmed | Paradigm shift of drug information centers during the COVID-19 pandemic |
title_short | Paradigm shift of drug information centers during the COVID-19 pandemic |
title_sort | paradigm shift of drug information centers during the covid-19 pandemic |
topic | Current Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370873/ https://www.ncbi.nlm.nih.gov/pubmed/32837192 http://dx.doi.org/10.1007/s40267-020-00757-3 |
work_keys_str_mv | AT khatiwadaasmitapriyadarshini paradigmshiftofdruginformationcentersduringthecovid19pandemic AT shakyasujyoti paradigmshiftofdruginformationcentersduringthecovid19pandemic AT shresthasunil paradigmshiftofdruginformationcentersduringthecovid19pandemic |